Information Provided By:
Fly News Breaks for April 8, 2018
PODD, DXCM
Apr 8, 2018 | 18:54 EDT
Piper Jaffray analyst JP McKim recommends investors own Dexcom (DXCM) and Insulet (PODD) into Q1 earnings where he expects strong results from both. That said, the analyst notes he is still actively monitoring payers/PBMs for Libre coverage and pricing pressure for Dexcom.